Sumitomo Pharma Co., Ltd.
- SEC CIK
- 0001446601
No open-market purchases or sales filed in the past year.
Current role at each company
- ROIV Roivant Sciences Ltd.10% Owneras of Jun 26, 2023
- MYOV Myovant Sciences Ltd.10% Owneras of Mar 10, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Sumitomo Pharma Co., Ltd. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ROIV Roivant Sciences Ltd.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 26, 2023 (view filing)4:05 PM ET | Jun 22 | 4 days | Sumitomo Pharma Co., Ltd. and 1 other10% Owner | SSale | −15.1M | $8.60 | −$130.0M | −17.5%71.3M after |
MYOV Myovant Sciences Ltd.
10% Owner17 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 2021 (view filing)5:05 PM ET | Aug 16-17 | 2 days | Sumitomo Pharma Co., Ltd. and 2 others10% Owner | PPurchase | +71.7K | $21.21 | +$1.52M | +0.1%48.7M after | 3 lots |
| Aug 20, 2021 (view filing)5:00 PM ET | Aug 18-19 | 2 days | Sumitomo Pharma Co., Ltd. and 2 others10% Owner | PPurchase | +63.9K | $21.49 | +$1.37M | +0.1%48.8M after | 2 lots |
| Aug 24, 2021 (view filing)5:00 PM ET | Aug 20-23 | 4 days | Sumitomo Pharma Co., Ltd. and 2 others10% Owner | PPurchase | +101.9K | $21.65 | +$2.21M | +0.2%48.9M after | 3 lots |
| Aug 26, 2021 (view filing)5:00 PM ET | Aug 24-25 | 2 days | Sumitomo Pharma Co., Ltd. and 2 others10% Owner | PPurchase | +63.0K | $22.40 | +$1.41M | +0.1%48.9M after | 2 lots |
| Aug 30, 2021 (view filing)5:00 PM ET | Aug 26-27 | 4 days | Sumitomo Pharma Co., Ltd. and 2 others10% Owner | PPurchase | +77.0K | $22.91 | +$1.77M | +0.2%49.0M after | 2 lots |
| Sep 1, 2021 (view filing)5:00 PM ET | Aug 30-31 | 2 days | Sumitomo Pharma Co., Ltd. and 2 others10% Owner | PPurchase | +109.0K | $24.05 | +$2.62M | +0.2%49.1M after | 2 lots |
| Sep 3, 2021 (view filing)5:00 PM ET | Sep 1-2 | 2 days | Sumitomo Pharma Co., Ltd. and 2 others10% Owner | PPurchase | +103.1K | $25.60 | +$2.64M | +0.2%49.2M after | 4 lots |
| Sep 8, 2021 (view filing)5:00 PM ET | Sep 3-7 | 5 days | Sumitomo Pharma Co., Ltd. and 2 others10% Owner | PPurchase | +64.4K | $26.49 | +$1.71M | +0.1%49.3M after | 4 lots |
| Sep 10, 2021 (view filing)5:00 PM ET | Sep 8-9 | 2 days | Sumitomo Pharma Co., Ltd. and 2 others10% Owner | PPurchase | +58.9K | $25.60 | +$1.51M | +0.1%49.4M after | 2 lots |
| Sep 14, 2021 (view filing)5:00 PM ET | Sep 10-13 | 4 days | Sumitomo Pharma Co., Ltd. and 2 others10% Owner | PPurchase | +113.2K | $23.84 | +$2.70M | +0.2%49.5M after | 3 lots |